RenaissanceRe (RNR) Tops Q4 EPS by 85c
Tweet
Share
E-mailGet Alerts RNR Hot Sheet
Price: $319.86 --0%
Financial Fact:
Net claims and claim expenses incurred: 112.58M
Today's EPS Names:
OTLK, EGRX, MOVE, More
Financial Fact:
Net claims and claim expenses incurred: 112.58M
Today's EPS Names:
OTLK, EGRX, MOVE, More
Join SI Premium – FREE
RenaissanceRe (NYSE: RNR) reported Q4 EPS of $7.33, $0.85 better than the analyst estimate of $6.48. Revenue for the quarter came in at $1.35 billion versus the consensus estimate of $1.49 billion.
For earnings history and earnings-related data on RenaissanceRe (RNR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
- Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c
- JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recover
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
